GCIA
IMDZ

Gabelli & Co Investment Advisers’s Immune Design Corp. IMDZ Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-591,650
Closed -$3.46M – 234
2019
Q1 		$3.46M Buy
+591,650
New +$2.02M 0.45% 50

Gabelli & Co Investment Advisers's IMDZ Position: Q2 2019 in Review

Gabelli & Co Investment Advisers sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 591,650 shares — an estimated $3.46M sold.

Gabelli & Co Investment Advisers first reported a position in IMDZ in Q1 2019 and held it in 1 quarter. The position peaked at $3.46M in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

  • Gabelli & Co Investment Advisers reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 591,650 Immune Design Corp. shares in Q2 2019, an estimated $3.46M.
  • Gabelli & Co Investment Advisers first reported a position in Immune Design Corp. in Q1 2019 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Immune Design Corp. position peaked at $3.46M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2019, filed 2 Aug 2019.